ArticleTranslational lung cancer research2022

Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer.

Dan-Hua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.